CHEBI:82699 - oritavancin

ChEBI IDCHEBI:82699
ChEBI Nameoritavancin
Stars
DefinitionA semisynthetic glycopeptide used (as its bisphosphate salt) for the treatment of acute bacterial skin and skin structure infections caused or suspected to be caused by susceptible isolates of designated Gram-positive microorganisms including MRSA.
Secondary ChEBI IDCHEBI:29553
Last Modified22 February 2017
Submittertmorrison
DownloadsMolfile
FormulaC86H97Cl3N10O26
Net Charge0
Average Mass1793.125
Monoisotopic Mass1790.56411
SMILESCN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O[C@H]3C[C@](C)(N)[C@@H](O)[C@H](C)O3)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(NCc3ccc(-c4ccc(Cl)cc4)cc3)[C@@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O
InChIInChI=1S/C86H97Cl3N10O26/c1-35(2)22-51(92-7)77(110)98-67-69(105)42-15-20-55(49(88)24-42)120-57-26-44-27-58(73(57)125-84-74(71(107)70(106)59(34-100)122-84)124-62-32-86(6,76(109)37(4)119-62)93-33-38-8-10-39(11-9-38)40-12-17-45(87)18-13-40)121-56-21-16-43(25-50(56)89)72(123-61-31-85(5,91)75(108)36(3)118-61)68-82(115)97-66(83(116)117)48-28-46(101)29-54(103)63(48)47-23-41(14-19-53(47)102)64(79(112)99-68)96-80(113)65(44)95-78(111)52(30-60(90)104)94-81(67)114/h8-21,23-29,35-37,51-52,59,61-62,64-72,74-76,84,92-93,100-103,105-109H,22,30-34,91H2,1-7H3,(H2,90,104)(H,94,114)(H,95,111)(H,96,113)(H,97,115)(H,98,110)(H,99,112)(H,116,117)/t36-,37-,51+,52-,59+,61-,62-,64+,65+,66-,67+,68-,69+,70+,71-,72+,74+,75-,76-,84-,85-,86-/m0/s1
InChIKeyVHFGEBVPHAGQPI-LXKZPTCJSA-N
Wikipedia
Roles Classification
Chemical Role:
Bronsted base  A molecular entity capable of accepting a hydron from a donor (Brønsted acid).
Biological Roles:
antibacterial drug  A drug used to treat or prevent bacterial infections.
antimicrobial agent  A substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans.
Application:
antibacterial drug  A drug used to treat or prevent bacterial infections.
ChEBI Ontology
Outgoing Relation(s)
oritavancin (CHEBI:82699) has functional parent vancomycin aglycone (CHEBI:47724)
oritavancin (CHEBI:82699) has role antibacterial drug (CHEBI:36047)
oritavancin (CHEBI:82699) has role antimicrobial agent (CHEBI:33281)
oritavancin (CHEBI:82699) is a disaccharide derivative (CHEBI:63353)
oritavancin (CHEBI:82699) is a glycopeptide (CHEBI:24396)
oritavancin (CHEBI:82699) is a semisynthetic derivative (CHEBI:72588)
Incoming Relation(s)
oritavancin bisphosphate (CHEBI:83305) has part oritavancin (CHEBI:82699)
Synonyms  Source
Chlorobiphenyl-chloroeremomycinKEGG COMPOUND
LY333328KEGG COMPOUND
(4''R)-22-O-(3-Amino-2,3,6-trideoxy-3-C-methyl-alpha-L-arabinohexopyranosyl)-N3''-(p-(p-chlorophenyl)benzyl)vancomycinChemIDplus
(4''R)-22-O-(3-amino-2,3,6-trideoxy-3-C-methyl-alpha-L-arabino-hexopyranosyl)-N3''-((4'-chloro(1,1'-biphenyl)-4-yl)methyl)vancomycinChEBI
Manual XrefsDatabases
C12034KEGG COMPOUND
OritavancinWikipedia
4678DrugCentral
Registry NumbersSources
Reaxys:7608605Reaxys
CAS:171099-57-3KEGG COMPOUND
CAS:171099-57-3ChemIDplus
Citations